Last updated: 20 August 2024 at 11:48am EST

Andrew Cheng Net Worth




The estimated Net Worth of Andrew Cheng is at least $23.8 millió dollars as of 16 August 2024. Andrew Cheng owns over 24,538 units of Akero Therapeutics Inc stock worth over $15,555,311 and over the last 5 years he sold AKRO stock worth over $2,783,269. In addition, he makes $5,431,810 as President, Chief Executive Officer és Director at Akero Therapeutics Inc.

Andrew Cheng AKRO stock SEC Form 4 insiders trading

Andrew has made over 39 trades of the Akero Therapeutics Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he exercised 24,538 units of AKRO stock worth $15,214 on 16 August 2024.

The largest trade he's ever made was exercising 75,000 units of Akero Therapeutics Inc stock on 4 March 2024 worth over $1,287,750. On average, Andrew trades about 17,016 units every 27 days since 2019. As of 16 August 2024 he still owns at least 607,155 units of Akero Therapeutics Inc stock.

You can see the complete history of Andrew Cheng stock trades at the bottom of the page.





Andrew Cheng biography

Dr. Andrew Cheng M.D., Ph.D. serves as President, Chief Executive Officer, Director of the Company. Dr. Cheng has served as our President and Chief Executive Officer since September 2018. Before joining the Company, Dr. Cheng was formerly at Gilead Sciences, Inc., a biotechnology company, as the Chief Medical Officer from March 2018 through September 2018, Executive Vice President from February 2015 through September 2018 and Senior Vice President from February 2009 through February 2015. During his nearly 20 year tenure, he was responsible for the clinical development for the HIV program resulting in 11 FDA/EMA approved products. His past responsibilities also included medical affairs and the creation of the development operations department (regulatory affairs, clinical operations, pharmacovigilance, project management, clinical pharmacology and biometrics) which covered clinical development support in multiple therapeutic areas including oncology, inflammation, respiratory, cardiovascular, HIV and liver diseases. Dr. Cheng has served on the board of directors of Syntimmune, Inc., a biotechnology company, which was acquired by Alexion. Dr. Cheng holds a B.A. in biology from the Johns Hopkins University and a M.D. and Ph.D. in cellular and molecular biology from Columbia University College of Physicians and Surgeons. He completed his internal medicine residency at UCLA and was board certified in internal medicine.

What is the salary of Andrew Cheng?

As the President, Chief Executive Officer és Director of Akero Therapeutics Inc, the total compensation of Andrew Cheng at Akero Therapeutics Inc is $5,431,810. There are no executives at Akero Therapeutics Inc getting paid more.



How old is Andrew Cheng?

Andrew Cheng is 53, he's been the President, Chief Executive Officer és Director of Akero Therapeutics Inc since 2018. There are 5 older and 8 younger executives at Akero Therapeutics Inc. The oldest executive at Akero Therapeutics Inc is Dr. Timothy Rolph, 67, who is the Co-Founder & Chief Scientific Officer.

What's Andrew Cheng's mailing address?

Andrew's mailing address filed with the SEC is C/O AKERO THERAPEUTICS, INC., 601 GATEWAY BOULEVARD, SUITE 350, SOUTH SAN FRANCISCO, CA, 94080.

Insiders trading at Akero Therapeutics Inc

Over the last 5 years, insiders at Akero Therapeutics Inc have traded over $146,260,704 worth of Akero Therapeutics Inc stock and bought 4,870,000 units worth $104,250,550 . The most active insiders traders include Group, Llc Green Jeremy Red..., Trust Blue Horizon Enterpri... és G. Walmsley Graham. On average, Akero Therapeutics Inc executives and independent directors trade stock every 11 days with the average trade being worth of $1,642,344. The most recent stock trade was executed by Jonathan Young on 3 September 2024, trading 5,000 units of AKRO stock currently worth $133,600.



What does Akero Therapeutics Inc do?

akero therapeutics is developing best-in-class medicines that restore metabolic balance to treat non-alcoholic steatohepatitis (nash) and other serious metabolic diseases. akero's lead clinical program, akr-001, is a long-acting fc fusion modified fgf21 protein and potential best-in-class treatment for nash. akr-001 builds upon two decades of work on fgf21 biology. it is designed to affect both the liver and adipose tissue, reducing liver fat and suppressing inflammation and fibrosis.



What does Akero Therapeutics Inc's logo look like?

Akero Therapeutics Inc logo

Complete history of Andrew Cheng stock trades at Arbutus Biopharma Corp és Akero Therapeutics Inc

Dátum
#
Cég
Az érdekelt
Trans.
Tranzakció
Részvények száma Ár per részvény Teljes ár Részvények szíma után Forrás
16 Aug 2024 Andrew Cheng
elnök és CEO
Opció Gyakorlat 24,538 $0.62 $15,214
16 Aug 2024
607,155
11 Jun 2024 Andrew Cheng
elnök és CEO
Eladás 7,894 $22.64 $178,720
11 Jun 2024
581,553
13 Mar 2024 Andrew Cheng
elnök és CEO
Eladás 1,969 $28.33 $55,782
13 Mar 2024
589,447
4 Mar 2024 Andrew Cheng
elnök és CEO
Opció Gyakorlat 75,000 $17.17 $1,287,750
4 Mar 2024
666,416
2 Jan 2024 Andrew Cheng
elnök és CEO
Opció Gyakorlat 40,000 $0.62 $24,800
2 Jan 2024
590,911
14 Dec 2023 Andrew Cheng
elnök és CEO
Eladás 1,628 $20.76 $33,797
14 Dec 2023
550,911
7 Dec 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 26,978 $6.36 $171,580
7 Dec 2023
559,944
2 Oct 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $6.36 $159,000
2 Oct 2023
485,998
13 Sep 2023 Andrew Cheng
elnök és CEO
Eladás 1,682 $50.34 $84,672
13 Sep 2023
460,998
1 Sep 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $6.36 $159,000
1 Sep 2023
487,680
30 Aug 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 15,000 $0.62 $9,300
30 Aug 2023
462,680
1 Aug 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $6.36 $159,000
1 Aug 2023
472,680
3 Jul 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $6.36 $159,000
3 Jul 2023
472,680
27 Jun 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 40,000 $0.62 $24,800
27 Jun 2023
447,680
13 Jun 2023 Andrew Cheng
elnök és CEO
Eladás 1,613 $55.16 $88,973
13 Jun 2023
407,680
1 Jun 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $1.46 $36,500
1 Jun 2023
434,293
18 Apr 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 65,000 $0.62 $40,300
18 Apr 2023
434,293
3 Apr 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $0.62 $15,500
3 Apr 2023
394,293
1 Mar 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $0.62 $15,500
1 Mar 2023
395,999
1 Feb 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $0.62 $15,500
1 Feb 2023
395,999
3 Jan 2023 Andrew Cheng
elnök és CEO
Opció Gyakorlat 25,000 $0.62 $15,500
3 Jan 2023
395,999
16 Dec 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 8,500 $0.62 $5,270
16 Dec 2022
370,999
1 Dec 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 10,000 $0.62 $6,200
1 Dec 2022
320,148
1 Nov 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 10,000 $0.62 $6,200
1 Nov 2022
320,148
3 Oct 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 10,000 $0.62 $6,200
3 Oct 2022
320,148
13 Sep 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 60,000 $0.62 $37,200
13 Sep 2022
370,148
1 Mar 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 10,000 $0.62 $6,200
1 Mar 2022
318,996
1 Feb 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 10,000 $0.62 $6,200
1 Feb 2022
318,996
10 Jan 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 10,000 $0.62 $6,200
10 Jan 2022
308,996
3 Jan 2022 Andrew Cheng
elnök és CEO
Opció Gyakorlat 53,000 $0.62 $32,860
3 Jan 2022
308,996
2 Dec 2021 Andrew Cheng
elnök és CEO
Eladás 17,500 $20.18 $353,150
2 Dec 2021
255,996
2 Nov 2021 Andrew Cheng
elnök és CEO
Eladás 17,500 $22.57 $394,975
2 Nov 2021
273,496
4 Oct 2021 Andrew Cheng
elnök és CEO
Eladás 17,500 $21.54 $376,950
4 Oct 2021
290,996
2 Sep 2021 Andrew Cheng
elnök és CEO
Eladás 17,500 $23.89 $418,075
2 Sep 2021
308,496
3 Aug 2021 Andrew Cheng
elnök és CEO
Eladás 17,500 $20.83 $364,525
3 Aug 2021
325,996
2 Jul 2021 Andrew Cheng
elnök és CEO
Eladás 17,500 $24.78 $433,650
2 Jul 2021
342,489
7 Jan 2021 Andrew Cheng
elnök és CEO
Opció Gyakorlat 20,000 $0.62 $12,400
7 Jan 2021
362,989
28 Dec 2020 Andrew Cheng
elnök és CEO
Opció Gyakorlat 7,480 $0.62 $4,638
28 Dec 2020
342,989
21 Dec 2020 Andrew Cheng
elnök és CEO
Opció Gyakorlat 10,500 $0.62 $6,510
21 Dec 2020
335,509


Akero Therapeutics Inc executives and stock owners

Akero Therapeutics Inc executives and other stock owners filed with the SEC include: